Consensus McKesson Corporation

Stocks

MCK

US58155Q1031

Pharmaceuticals

Market Closed - NYSE 16:00:02 2026-10-12 EDT			5-day change	1st Jan Change
955.76 ^USD	+1.80%		+4.40%	+16.51%

10-12	Baird Adjusts Price Target on McKesson to $1,017 From $1,015	MT
10-07	Leerink Partners Adjusts Price Target on McKesson to $1,070 From $1,030	MT

Evolution of the Average Target: McKesson Corporation

Evolution of the Target Price: McKesson Corporation

Changes in Analyst Recommendations: McKesson Corporation

bea3c71f9cf40679a2.UZlJfkWKVppdeuO3xlvguY89LWAKtoZy_6TgYUQEHt4.NN4HMTDte_4kO5LPgQ-E1NVWXBdI_NUbpdaMO3Y3bO4V1z0aDfwP3jMQsg~a892269ed974656bb624334a70b448cc

Analysts' recommendations: McKesson Corporation

10-12	Baird Adjusts Price Target on McKesson to $1,017 From $1,015	MT
10-07	Leerink Partners Adjusts Price Target on McKesson to $1,070 From $1,030	MT
10-07	Truist Downgrades Option Care Health to Buy From Hold on Heels of Announced Sale to McKesson, CD&R; Adjusts PT to $32.05 From $30	MT
09-14	McKesson Continues to Face Medium-Term Headwinds From Declining Employer Coverage of GLP-1, RBC Says	MT
09-03	Argus Adjusts Price Target on McKesson to $970 From $850, Maintains Buy Rating	MT
08-19	McKesson's Specialty Drug Mix Helps Cushion Pricing Pressure, RBC Says	MT
08-19	RBC Initiates McKesson at Sector Perform With $845 Price Target	MT
08-18	Barclays Raises Price Target on McKesson to $1,000 From $925, Maintains Overweight Rating	MT
08-11	Wells Fargo Adjusts Price Target on McKesson to $933 From $812, Maintains Equalweight Rating	MT
08-06	Mizuho Adjusts Price Target on McKesson to $905 From $885	MT
08-06	TD Cowen Adjusts Price Target on McKesson to $1,006 From $989	MT
08-06	Evercore ISI Adjusts Price Target on McKesson to $1,000 From $860	MT
08-06	Baird Adjusts Price Target on McKesson to $1,015 From $955	MT
08-06	UBS Adjusts Price Target on McKesson to $1,080 From $1,050, Maintains Buy Rating	MT
08-06	BofA Securities Adjusts Price Target on McKesson to $1,050 From $950	MT
07-23	Citigroup Raises McKesson Price Target to $1,000 From $945, Maintains Buy Rating	MT
07-22	Baird Adjusts Price Target on McKesson to $955 From $941, Maintains Outperform Rating	MT
07-21	TD Cowen Adjusts McKesson Price Target to $989 From $1,012, Maintains Buy Rating	MT
07-21	BofA Securities Adjusts McKesson Price Target to $925 From $900	MT
07-14	Leerink Partners Adjusts Price Target on McKesson to $950 From $970, Maintains Outperform Rating	MT
07-07	Evercore ISI Adjusts Price Target on McKesson to $860 From $850	MT
06-10	Barclays Cuts McKesson Price Target to $925 From $1,050, Maintains Overweight Rating	MT
06-05	Argus Adjusts Price Target on McKesson to $850 From $1,050, Maintains Buy Rating	MT
05-14	Citigroup Adjusts Price Target on McKesson to $945 From $975, Maintains Buy Rating	MT
05-12	Wells Fargo Adjusts Price Target on McKesson to $812 From $925, Maintains Equalweight Rating	MT

More recommendations

Pharmaceuticals Wholesale

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	MCKESSON CORPORATION					+4.46%
	ELI LILLY AND COMPANY					+12.79%
	JOHNSON & JOHNSON					+7.03%
	ABBVIE INC.					+2.22%
	MERCK & CO., INC.					+8.54%
	ROCHE HOLDING AG					+5.14%
	NOVARTIS AG					+4.76%
	ASTRAZENECA PLC					+31.69%
	AMGEN INC.					-4.73%
	GILEAD SCIENCES, INC.					+5.43%
	Average					+7.73%
	Weighted average by Cap.					+8.52%